Company Search:
Advanced Search
Sponsored Links
Siegfried Holding AG Company Snapshot
Siegfried Holding AG operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Siegfried Holding AG with three other pharmaceutical manufacturers in Europe: Swedish Orphan Biovitrum AB (publ) of Sweden (2017 sales of 6.51 billion Swedish Kronor [US$774.72 million] ), Boiron SA of France (617.54 million Euro [US$764.28 million] ), and Diasorin S.P.A. which is based in Italy (637.49 million Euro [US$788.97 million] ).

Sales Analysis. Siegfried Holding AG reported sales of 750.47 million Swiss Francs (US$774.48 million) for the year ending December of 2017. This represents an increase of 4.6% versus 2016, when the company's sales were 717.73 million Swiss Francs. This was the third consecutive year of growth at Siegfried Holding AG. Sales of Drug Products saw an increase of 6.3% in 2017, from 159.80 million Swiss Francs to 169.80 million Swiss Francs.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Siegfried Holding AG
  Stock Performance Chart for Siegfried Holding AG
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 342.00
(Figures in Swiss Francs)
1 Week 3.3%   13 Weeks 2.4%  
4 Weeks 4.3%   52 Weeks 23.5%  
Siegfried Holding AG Key Data:
  Ticker: SFZN Country: Switzerland
  Exchanges: ZHR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2017 Sales 750,468,000
(Year Ending Jan 2018).
Employees: 2,260
  Currency: Swiss Francs Market Cap: 1,416,674,808
  Fiscal Yr Ends: December Shares Outstanding: 4,142,324
  Share Type: Namenaktie Closely Held Shares: 529,057
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.